Allergan agrees $600m settlement for unapproved Botox marketing
Sep 3, 2010 Record Label
Allergan agrees $600m settlement for unapproved Botox marketing
CHICAGO – Allergan Inc has agreed to pay $600 million to settle a federal investigation of its marketing practices for the injectable wrinkle smoother Botox.
Read more on The Irish Times
Tags: $600m, agrees, Allergan, Botox, Marketing, settlement, unapproved